Medicines Discovery Catapult (MDC) is enabling the community to reshape medicines discovery in the UK. It is ambitious, and it is achievable.
We do this by championing innovative life science technology and new approaches, supporting UK innovators to succeed.
We are helping to industrialise and drive the adoption of new techniques and technologies.
We are driven by helping our community make their mark on the industry and patients.If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.
University of Exeter and Medicines Discovery Catapult combine to industrialise academic medicines research
Today, the University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to accelerate medicines Research & Development (R&D), creating value for the
Global mental health care company, COMPASS Pathways has joined the Psychiatry Consortium, bringing additional expertise and insights to the group. A company dedicated to accelerating
The Alderley Park Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s national COVID testing, last week processed its 4 millionth